Meitav Investment House Ltd. increased its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 18.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,792 shares of the biotechnology company’s stock after purchasing an additional 2,667 shares during the […]
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH acquired a new position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 1,675 shares of the biotechnology company’s stock, valued at approximately $430,000. Other hedge funds and other institutional […]
Rovin Capital UT ADV lowered its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 9.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,582 shares of the biotechnology company’s stock after selling 165 shares during the period. Rovin Capital UT ADV’s holdings in Biogen […]
Horizon Bancorp Inc. IN grew its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 361.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 411 shares of the biotechnology company’s stock after buying an additional 322 shares during the quarter. […]
Robeco Institutional Asset Management B.V. trimmed its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 341,810 shares of the biotechnology company’s stock after selling 1,407 shares during the […]